The Government of China has made a commitment (Chinese) to supporting the development of substitutes for endangered wildlife used in traditional Chinese medicine (TCM). The announcement by the National Medical Products Administration of China (NMPA) is an encouraging step towards ending the use of threatened wildlife in TCM and represents tangible progress following a proposal […]
In this episode of the podcast, EIA’s Senior Press and Communications Officer Paul Newman talks with EIA US Executive Director Alexander von Bismarck about the changes he’s seen in the organisation and the challenges it faces in the future
Today, we’re sharing a flashback to a film we made in 2015 to accompany a major Wildlife team investigation and report into Laos’ notorious Sin City
EIA sent teams of campaigners from our UK and US offices to the 77th meeting of the Standing Committee (SC77) of the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES)
Illegal wildlife trade is happening on a large scale to supply the parts and products of protected species such as leopards, pangolins, rhinos and tigers to serve as ingredients in some traditional Chinese medicines – and some big international household names are invested
A new EIA UK investigation has found the body parts of threatened leopards and pangolins being used as ingredients in at least 88 traditional Chinese medicine (TCM) products Manufactured by 72 Chinese companies and licensed by the National Medical Products Administration of China, some of those identified also contain tiger and rhino, in contravention of […]